(PRESS RELEASE) BUCHAREST, Romania, 14-Apr-2020 — /EuropaWire/ — In light of the public health risks caused by the COVID-19 pandemic and the restrictive measures implemented in the Netherlands and elsewhere concerning the gatherings of people, Digi Communications N.V. (the Company) … Read the full press release
Posted in Business, Financial, Investment, Law, Media, Netherlands, News, Romania, Technology, Telecom
Tagged admission to trading, AFM, Android TV-based entertainment service, ASF, Bogdan Ciobotaru, Bucharest Stock Exchange, Business Continuity, buy back shares, buy-back program, BVB, Class A shares, Class B shares, conference call, coronavirus, COVID-19, Digi, DIGI 2019 Annual Report, DIGI 2019 Financial Statements, DIGI Annual Report 2019, Digi Communications, Digi Communications 2018 Preliminary financial results, Digi Communications Conference Call, Digi Communications N.V. AGM 2020, Digi Communications NV, DIGI GSM 2020, DIGI symbol, DIGI symbol 20 - 24 Jan 2020 transactions, directors stock option plans, Dutch Authority for the Financial Markets, Emil Jugaru, employees stock option plans, equity reserves, Euronext Dublin, financial transactions, General Shareholders Meeting, Hungary, Investor Relations, investors, IPO, Irish Stock Exchange, Marius Catalin Varzaru, market, mobile services, MVNO, Piotr Rymaszewski, regulated market, Regulation, Romania, Romanian Financial Supervisory Authority, Romanian National Securities Commission, romanian telecommunications provider, Securities, senior secured notes, Serghei Bulgac, shareholders, shares, shares buy-back, shares conversion, Spain, stock option plans, Telecom Market, TELECOMMUNICATION PROVIDER, telecommunications, telecommunications services, transactions, tv
The trial, called CALAVI, will assess the effect of Calquence on the exaggerated immune response of patients hospitalised with COVID-19 infection (PRESS RELEASE) CAMBRIDGE, 14-Apr-2020 — /EuropaWire/ — Pharmaceutical giant AstraZeneca to begin a randomised, global clinical trial to assess … Read the full press release
Posted in Healthcare, Science, Sweden, Technology, United Kingdom
Tagged assisted ventilation, AstraZeneca, best supportive care, blood cancers, Bruton’s tyrosine kinase, BSC, BTK, BTK inhibitor, CALAVI, Calquence, clinical trial, COVID-19, cytokine storm, exaggerated immune response, inflammatory cytokines, José Baselga, Louis M. Staudt M.D. Ph.D., lung disease
(PRESS RELEASE) LUND, 14-Apr-2020 — /EuropaWire/ — Alfa Laval wins two orders to supply Framo pumping systems to two customers in China and Singapore. The orders are worth approximately EUR 15.5 million (SEK 170 million). The bookings were recorded late … Read the full press release
(PRESS RELEASE) LUND, 14-Apr-2020 — /EuropaWire/ — Alfa Laval announces the launch of a unique separator system, Alfa Laval CultureOne™, for single-use processing in the biopharmaceutical industry. With Alfa Laval CultureOne™ system the risk of cross-contamination is eliminated with the … Read the full press release
(PRESS RELEASE) STOCKHOLM, 14-Apr-2020 — /EuropaWire/ — Skanska and Amtrak sign contract for the rehabilitation and restoration of maintenance facilities for the Next Generation Acela 21 high-speed rail service in Washington, D.C., Boston, and New York, USA. The USD 40 … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?